{"id":8584,"date":"2025-08-19T14:56:00","date_gmt":"2025-08-19T06:56:00","guid":{"rendered":"https:\/\/regask.com\/?page_id=8584"},"modified":"2026-09-11T18:15:54","modified_gmt":"2026-09-11T10:15:54","slug":"industrie-pharmaceutique-japonaise-2025","status":"publish","type":"page","link":"https:\/\/regask.com\/fr\/events\/pharma-japan-2025\/","title":{"rendered":"Pharma Japon 2025"},"content":{"rendered":"<section class=\"section\" id=\"section_188647611\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/06\/Careers-header-bg.svg\" class=\"bg attachment-medium_large size-medium_large\" alt=\"En-t\u00eate Carri\u00e8res Bg\" \/>\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row row-large align-middle align-center\"  id=\"row-154986082\">\n\n\t<div id=\"col-1211558535\" class=\"col medium-5 small-12 large-5\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover no-margin x md-x lg-x y md-y lg-y\" id=\"image_1677217575\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"720\" height=\"720\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png\" class=\"attachment-medium_large size-medium_large\" alt=\"Page d&#039;accueil de Regask Pharma Japan 2025\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png 720w, https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page-330x330.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page-12x12.png 12w\" sizes=\"auto, (max-width: 720px) 100vw, 720px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_1677217575 {\n  width: 90%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1211558535 > .col-inner {\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-618913934\" class=\"col medium-6 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h5><span style=\"font-size: 95%;\" data-text-color=\"secondary\">REGASK REJOINT<\/span><\/h5>\n<h1 class=\"mt-&#091;1rem&#093; md:mt-&#091;1.5rem&#093; t-h1 text-white\">Pharma Japon 2025<\/h1>\n<div class=\"is-divider divider clearfix\" style=\"max-width:40px;background-color:rgb(145, 138, 215);\"><\/div>\n\t<div id=\"text-1941349952\" class=\"text\">\n\t\t\n<p data-line-height=\"s\"><span data-text-color=\"primary\"><strong>9-10 SEPTEMBRE 2025 | JAPON<\/strong><\/span><\/p>\n<p data-line-height=\"s\"><span data-text-color=\"primary\"><strong>Le Westin, Tokyo<\/strong><\/span><\/p>\n\t\t\n<style>\n#text-1941349952 {\n  text-align: left;\n  color: rgb(227, 227, 227);\n}\n#text-1941349952 > * {\n  color: rgb(227, 227, 227);\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/fr\/reunion-annuelle-de-2025-a-singapour\/#register20\" class=\"button secondary hide-for-small\" >\n\t\t<span>Retrouvez-nous \u00e0 Pharma Japan 2025<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/regask.com\/fr\/reunion-annuelle-de-2025-a-singapour\/#register20\" class=\"button secondary show-for-small\" >\n\t\t<span>Retrouvez-nous au DIA Singapour 2025<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<style>\n#row-154986082 > .col > .col-inner {\n  padding: 30px 0px 0px 0px;\n}\n<\/style>\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_188647611 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n@media (min-width:550px) {\n  #section_188647611 {\n    padding-top: 30px;\n    padding-bottom: 30px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n<span class=\"scroll-to\" data-label=\"Scroll to: #register20\" data-bullet=\"false\" data-link=\"#register20\" data-title=\"Register\"><a name=\"register20\"><\/a><\/span>\n<div class=\"row row-collapse row-full-width\"  id=\"row-892906492\">\n\n\t<div id=\"col-998732574\" class=\"col medium-12 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section dark\" id=\"section_831189096\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-2095009165\">\n\n\t<div id=\"col-249317925\" class=\"col medium-9 small-12 large-9\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"text-2670436944\" class=\"text\">\n\t\t\n<h3>Rencontrez notre \u00e9quipe \u00e0 Pharma Japan 2025<\/h3>\n\t\t\n<style>\n#text-2670436944 {\n  font-size: 1.5rem;\n  text-align: left;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"gap-2110972369\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2110972369 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-1727180423\" class=\"text\">\n\t\t\n<p data-start=\"100\" data-end=\"441\">Rejoindre <strong data-start=\"105\" data-end=\"141\">Caroline Shleifer, fondatrice et PDG<\/strong>, et <strong data-start=\"147\" data-end=\"194\">Oliver Stein, directeur du d\u00e9veloppement commercial<\/strong>, car ils repr\u00e9sentent RegASK \u00e0 <strong data-start=\"224\" data-end=\"245\">Pharma Japon 2025<\/strong>. Caroline montera sur sc\u00e8ne avec une conf\u00e9rence sur <em data-start=\"302\" data-end=\"369\">Agentic AI x Regulatory Intelligence\u00a0: du fardeau \u00e0 la perc\u00e9e<\/em>, partageant la mani\u00e8re dont les agents d&#039;IA intelligents red\u00e9finissent les affaires r\u00e9glementaires.<\/p>\n<p data-start=\"443\" data-end=\"616\">Il s&#039;agit d&#039;une excellente occasion de se connecter, d&#039;explorer l&#039;intelligence r\u00e9glementaire bas\u00e9e sur l&#039;IA et de voir comment RegASK permet une conformit\u00e9 plus intelligente et plus rapide sur les march\u00e9s dynamiques des sciences de la vie.<\/p>\n\t\t\n<style>\n#text-1727180423 {\n  text-align: left;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-249317925 > .col-inner {\n  margin: 0px 40px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row align-center\"  id=\"row-1603301850\">\n\n\t<div id=\"col-1408823560\" class=\"col medium-9 small-12 large-9\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"box has-hover   has-hover box-default box-text-bottom\" >\n\n\t\t<div class=\"box-image\" >\n\t\t\t\t\t\t<div class=\"\" >\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"979\" height=\"401\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/Pharma-Japan-2025-attendees-5.png\" class=\"attachment- size-\" alt=\"5 participants \u00e0 Pharma Japan 2025\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/Pharma-Japan-2025-attendees-5.png 979w, https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/Pharma-Japan-2025-attendees-5-330x135.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/Pharma-Japan-2025-attendees-5-18x7.png 18w\" sizes=\"auto, (max-width: 979px) 100vw, 979px\" \/>\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\t<div class=\"box-text text-center is-small\" >\n\t\t\t<div class=\"box-text-inner\">\n\t\t\t\t\n\t<div id=\"gap-1486952948\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1486952948 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<div class=\"row align-center\"  id=\"row-806634976\">\n\n\t<div id=\"col-415718496\" class=\"col medium-6 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p><span style=\"font-size: 100%;\"><strong>Olivier Stein<\/strong><\/span><\/p>\n<p>Directeur du d\u00e9veloppement commercial<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-511249990\" class=\"col medium-6 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p><span style=\"font-size: 100%;\"><strong>Caroline Shleifer<\/strong><\/span><\/p>\n<p>Fondateur et PDG<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_831189096 {\n  padding-top: 70px;\n  padding-bottom: 70px;\n  min-height: 800px;\n  background-color: rgb(10, 35, 66);\n}\n@media (min-width:550px) {\n  #section_831189096 {\n    padding-top: 30px;\n    padding-bottom: 30px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-925056101\" class=\"col medium-12 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section dark\" id=\"section_1696838784\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-2024690390\">\n\n\t<div id=\"col-1336549433\" class=\"col medium-10 small-12 large-10\"  data-animate=\"fadeInRight\">\n\t\t\t\t<div class=\"col-inner text-center box-shadow-2\" style=\"background-color:rgb(255, 255, 255);\" >\n\t\t\t\n\t\t\t\n\n<p><script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/embed\/v2.js\"><\/script><br \/>\n<script>\n  hbspt.forms.create({\n    portalId: \"20908020\",\n    formId: \"c5958a92-9a17-41d3-a4e6-c5032e3156ff\",\n    region: \"na1\"\n  });\n<\/script><br \/>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1336549433 > .col-inner {\n  padding: 30px 30px 30px 30px;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1696838784 {\n  padding-top: 70px;\n  padding-bottom: 70px;\n  min-height: 800px;\n  background-color: rgb(251, 250, 254);\n}\n@media (min-width:550px) {\n  #section_1696838784 {\n    padding-top: 0px;\n    padding-bottom: 0px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\n\t<section class=\"section\" id=\"section_296969975\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t<img decoding=\"async\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/bg-flip-card-1.svg\" class=\"bg attachment- size-\" alt=\"Carte \u00e0 retourner Bg 1\" \/>\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row\"  id=\"row-516746397\">\n\n\t<div id=\"col-726680590\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2 class=\"mt-&#091;1rem&#093; md:mt-&#091;1.5rem&#093; t-h1 text-white\">Pharma Japon 2025<\/h2>\n\t<div id=\"text-3071306801\" class=\"text\">\n\t\t\n<p><strong data-start=\"597\" data-end=\"634\">\u00c9v\u00e9nements Reuters\u00a0: Pharma Japan 2025<\/strong> est <strong data-start=\"638\" data-end=\"694\">La plus grande et la seule conf\u00e9rence des dirigeants de l&#039;industrie pharmaceutique au Japon<\/strong>, r\u00e9unissant les meilleurs dirigeants des secteurs commercial, des ventes, du marketing, m\u00e9dical, de l&#039;engagement des patients, des RWE, clinique, de l&#039;acc\u00e8s au march\u00e9, du num\u00e9rique, de l&#039;informatique et bien plus encore pour fa\u00e7onner l&#039;avenir de l&#039;innovation pharmaceutique japonaise<\/p>\n<h3><span style=\"font-size: 85%;\">Les th\u00e8mes cl\u00e9s incluent :<\/span><\/h3>\n<ul>\n<li data-start=\"966\" data-end=\"1027\">Le passage urgent vers une <strong data-start=\"992\" data-end=\"1027\">mod\u00e8le d&#039;entreprise centr\u00e9 sur le client<\/strong><\/li>\n<li data-start=\"966\" data-end=\"1027\">Int\u00e9gration de <strong data-start=\"1045\" data-end=\"1104\">commercial, marketing, R&amp;D, clinique, donn\u00e9es et num\u00e9rique<\/strong> fonctions centr\u00e9es sur l&#039;exp\u00e9rience du patient<\/li>\n<li data-start=\"966\" data-end=\"1027\"><strong data-start=\"1193\" data-end=\"1210\">Innovation en IA<\/strong> pour personnaliser l&#039;engagement et optimiser les ressources, en mettant en avant une programmation interactive et exploitable telle que des d\u00e9bats, des hackathons et des discussions pilotes r\u00e9elles<\/li>\n<\/ul>\n<h3><span style=\"font-size: 85%;\">Lieu et horaire :<\/span><\/h3>\n<p data-start=\"1434\" data-end=\"1515\">\ud83d\udccd The Westin Tokyo, 1 Chome-4-1 Mita, Meguro City, Tokyo 153-8580, Japon<br data-start=\"151\" data-end=\"154\" \/>\ud83d\uddd3 9-10 septembre 2025 | 9h00 \u2013 17h00 (GMT+9)<\/p>\n\t\t\n<style>\n#text-3071306801 {\n  text-align: left;\n  color: rgb(17, 59, 111);\n}\n#text-3071306801 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"gap-1101206081\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1101206081 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h3 class=\"mt-&#091;1rem&#093; md:mt-&#091;1.5rem&#093; t-h1 text-white\">Ce que RegASK apporte \u00e0 l&#039;industrie pharmaceutique<\/h3>\n\t<div id=\"gap-1280517346\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1280517346 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-2475723201\" class=\"text\">\n\t\t\n<p data-start=\"241\" data-end=\"389\">Chez RegASK, nous accompagnons les entreprises pharmaceutiques avec <strong data-start=\"293\" data-end=\"330\">Intelligence r\u00e9glementaire pilot\u00e9e par l&#039;IA<\/strong> pour les aider \u00e0 garder une longueur d\u2019avance dans un paysage en \u00e9volution rapide.<\/p>\n<p data-start=\"391\" data-end=\"437\"><strong data-start=\"391\" data-end=\"435\">Voici comment nous ajoutons de la valeur \u00e0 l\u2019industrie :<\/strong><\/p>\n<ul data-start=\"438\" data-end=\"951\">\n<li data-start=\"438\" data-end=\"528\">\n<p data-start=\"440\" data-end=\"528\"><strong data-start=\"440\" data-end=\"480\">Naviguer dans la r\u00e9glementation complexe du Japon<\/strong> avec suivi et avis d&#039;experts<\/p>\n<\/li>\n<li data-start=\"529\" data-end=\"626\">\n<p data-start=\"531\" data-end=\"626\"><strong data-start=\"531\" data-end=\"566\">Acc\u00e9l\u00e9rer les flux de travail de conformit\u00e9<\/strong> gr\u00e2ce \u00e0 l&#039;automatisation bas\u00e9e sur l&#039;IA et \u00e0 l&#039;intelligence pr\u00e9dictive<\/p>\n<\/li>\n<li data-start=\"627\" data-end=\"726\">\n<p data-start=\"629\" data-end=\"726\"><strong data-start=\"629\" data-end=\"665\">Assurer l&#039;alignement global-local<\/strong> pour les strat\u00e9gies de r\u00e9glementation pharmaceutique dans la r\u00e9gion APAC et dans le monde entier<\/p>\n<\/li>\n<li data-start=\"727\" data-end=\"822\">\n<p data-start=\"729\" data-end=\"822\"><strong data-start=\"729\" data-end=\"767\">R\u00e9duire les risques et optimiser les ressources<\/strong> avec des alertes proactives et des recommandations exploitables<\/p>\n<\/li>\n<li data-start=\"823\" data-end=\"951\">\n<p data-start=\"825\" data-end=\"951\"><strong data-start=\"825\" data-end=\"847\">Favoriser l&#039;innovation<\/strong> en lib\u00e9rant les \u00e9quipes pour se concentrer sur les initiatives centr\u00e9es sur le patient tandis que RegASK g\u00e8re les complexit\u00e9s de conformit\u00e9<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"953\" data-end=\"1100\">En combinant l\u2019expertise r\u00e9glementaire avec l\u2019IA avanc\u00e9e, RegASK permet aux entreprises pharmaceutiques de fournir de l\u2019innovation avec confiance, rapidit\u00e9 et conformit\u00e9.<\/p>\n\t\t\n<style>\n#text-2475723201 {\n  text-align: left;\n  color: rgb(17, 59, 111);\n}\n#text-2475723201 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"gap-1961079515\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1961079515 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/fr\/reunion-annuelle-de-2025-a-singapour\/#register20\" class=\"button secondary hide-for-small\" >\n\t\t<span>Retrouvez-nous \u00e0 Pharma Japan 2025 !<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/regask.com\/fr\/reunion-annuelle-de-2025-a-singapour\/#register20\" class=\"button secondary show-for-small\" >\n\t\t<span>Retrouvez-nous au DIA Singapour 2025 !<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_296969975 {\n  padding-top: 60px;\n  padding-bottom: 60px;\n  background-color: rgb(255, 255, 255);\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_2129191827\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-equal align-center\"  id=\"row-1764487235\">\n\n\t<div id=\"col-1149534131\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Notre solution<\/h2>\n<p>RegASK s&#039;appuie sur l&#039;IA avanc\u00e9e et l&#039;apprentissage automatique pour aider les entreprises des secteurs hautement r\u00e9glement\u00e9s \u00e0 rationaliser leurs processus de conformit\u00e9 r\u00e9glementaire et \u00e0 garder une longueur d&#039;avance. Notre solution de pointe automatise la recherche r\u00e9glementaire, fournit des informations essentielles et permet aux \u00e9quipes des affaires r\u00e9glementaires de devenir des partenaires strat\u00e9giques pour stimuler la croissance de l&#039;entreprise.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1149534131 > .col-inner {\n  padding: 0px 0px 0px 0px;\n}\n@media (min-width:550px) {\n  #col-1149534131 > .col-inner {\n    padding: 0px 50px 0px 50px;\n  }\n}\n@media (min-width:850px) {\n  #col-1149534131 > .col-inner {\n    padding: 0px 170px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-211696613\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/RegGenius-Product-Icon-2.svg\" class=\"attachment-medium size-medium\" alt=\"Ic\u00f4ne de produit Reggenius (2)\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-973400286\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegGenius<\/h4>\n\t\t\n<style>\n#text-973400286 {\n  color: rgb(10, 35, 66);\n}\n#text-973400286 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-693265774\" class=\"text\">\n\t\t\n<p>Exploitez la puissance de l\u2019IA pour obtenir un avantage concurrentiel en mati\u00e8re de conformit\u00e9 r\u00e9glementaire.<br \/>\n\t\t\n<style>\n#text-693265774 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-693265774 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-211696613 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-632643326\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/Alerts-icon.svg\" class=\"attachment-medium size-medium\" alt=\"Ic\u00f4ne d&#039;alertes\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-2503336675\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">Alerte d&#039;inscription<\/h4>\n\t\t\n<style>\n#text-2503336675 {\n  color: rgb(10, 35, 66);\n}\n#text-2503336675 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-3991783690\" class=\"text\">\n\t\t\n<p>Aucune surprise avec la surveillance r\u00e9glementaire automatis\u00e9e.<br \/>\n\t\t\n<style>\n#text-3991783690 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-3991783690 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-632643326 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-745464831\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/Data-Driven-Excellence-icon.svg\" class=\"attachment-medium size-medium\" alt=\"Ic\u00f4ne d&#039;excellence ax\u00e9e sur les donn\u00e9es\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-578885181\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegInsights<\/h4>\n\t\t\n<style>\n#text-578885181 {\n  color: rgb(10, 35, 66);\n}\n#text-578885181 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-2830682974\" class=\"text\">\n\t\t\n<p>Identifiez les tendances, anticipez les risques et \u00e9laborez de meilleures strat\u00e9gies.<br \/>\n\t\t\n<style>\n#text-2830682974 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-2830682974 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-745464831 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1582472699\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/AskRegASK-Product-Icon.svg\" class=\"attachment-medium size-medium\" alt=\"Ic\u00f4ne du produit AskRegASK\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-158045282\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">Ask RegASK<\/h4>\n\t\t\n<style>\n#text-158045282 {\n  color: rgb(10, 35, 66);\n}\n#text-158045282 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-3454053919\" class=\"text\">\n\t\t\n<p>Acc\u00e9dez \u00e0 notre communaut\u00e9 d&#039;experts en la mati\u00e8re r\u00e9glementaire.<br \/>\n\t\t\n<style>\n#text-3454053919 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-3454053919 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1582472699 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 30px 0px;\n  border-radius: 30px;\n}\n@media (min-width:550px) {\n  #col-1582472699 > .col-inner {\n    margin: 0px 0px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_2129191827 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n  background-color: rgb(250, 250, 250);\n}\n@media (min-width:550px) {\n  #section_2129191827 {\n    padding-top: 60px;\n    padding-bottom: 60px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_2032346846\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-2136115359\">\n\n\t<div id=\"col-1613655156\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n<h2>Ressources<\/h2>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1613655156 > .col-inner {\n  padding: 50px 0px 0px 0px;\n  margin: 30px 0px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1680070817\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n  \n    <div class=\"row eneko-case-studies radius-30 large-columns-3 medium-columns-2 small-columns-1 slider row-slider slider-nav-simple slider-nav-outside slider-nav-push\"  data-flickity-options='{&quot;imagesLoaded&quot;: true, &quot;groupCells&quot;: &quot;100%&quot;, &quot;dragThreshold&quot; : 5, &quot;cellAlign&quot;: &quot;left&quot;,&quot;wrapAround&quot;: true,&quot;prevNextButtons&quot;: true,&quot;percentPosition&quot;: true,&quot;pageDots&quot;: true, &quot;rightToLeft&quot;: false, &quot;autoPlay&quot; : false}' >\n\n  <div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-government-shutdown-life-sciences-impact\/\" class=\"plain\" aria-label=\"Naviguer dans une \u00e9ventuelle fermeture du gouvernement am\u00e9ricain\u00a0: implications\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector.jpg\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"G\u00e9rer les implications potentielles d&#039;une fermeture du gouvernement am\u00e9ricain pour le secteur des sciences de la vie\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector.jpg 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector-330x248.jpg 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector-16x12.jpg 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">11 mars 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/blogs\/\">Blogs<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-government-shutdown-life-sciences-impact\/\" class=\"plain\">Naviguer dans une \u00e9ventuelle fermeture du gouvernement am\u00e9ricain\u00a0: implications\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tAlors que les l\u00e9gislateurs de Washington, DC, sont confront\u00e9s \u00e0 une \u00e9ch\u00e9ance critique, le 14 mars, pour finaliser les d\u00e9penses f\u00e9d\u00e9rales, la possibilit\u00e9 d&#039;un renversement du gouvernement am\u00e9ricain\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-government-shutdown-life-sciences-impact\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/blogs\/\" class=\"category-blogs\">Blogs<\/a> <a href=\"https:\/\/regask.com\/fr\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">\u00c9tats-Unis<\/a> <a href=\"https:\/\/regask.com\/fr\/category\/blogs\/pharma-and-biotech-news\/\" class=\"category-pharma-and-biotech-news\">Pharmaceutique et biotechnologie<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/2024-gartner-feature\/\" class=\"plain\" aria-label=\"RegASK pr\u00e9sent\u00e9 dans le guide de march\u00e9 de Gartner pour la r\u00e9glementation\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner.jpg\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Regask reconnu par Gartner comme un guide du march\u00e9\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner.jpg 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner-330x248.jpg 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner-16x12.jpg 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">21 novembre 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/company-news\/\">Actualit\u00e9s de l&#039;entreprise<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/2024-gartner-feature\/\" class=\"plain\">RegASK pr\u00e9sent\u00e9 dans le guide de march\u00e9 de Gartner pour la r\u00e9glementation\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tNous sommes ravis d&#039;annoncer que RegASK a \u00e9t\u00e9 inclus dans le Guide du march\u00e9 des solutions de veille r\u00e9glementaire de Gartner ! Cette reconnaissance \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/2024-gartner-feature\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/company-news\/\" class=\"category-company-news\">Actualit\u00e9s de l&#039;entreprise<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"plain\" aria-label=\"Rapport sur l\u2019\u00e9tat des affaires r\u00e9glementaires et de la conformit\u00e9 2025\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"800 600 Image en vedette du site Web\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">15 novembre 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/reports\/\">Rapports<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"plain\">Rapport sur l\u2019\u00e9tat des affaires r\u00e9glementaires et de la conformit\u00e9 2025\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tVotre organisation est-elle pr\u00eate \u00e0 affronter les complexit\u00e9s r\u00e9glementaires de 2025 ? Le paysage r\u00e9glementaire de 2025 est plus complexe que jamais, avec de nouvelles avanc\u00e9es\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/reports\/\" class=\"category-reports\">Rapports<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/doge-fda-lease-cancellations\/\" class=\"plain\" aria-label=\"Le DOGE revendique des \u00e9conomies de $30M gr\u00e2ce \u00e0 l&#039;annulation de 30 baux de la FDA\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Doge affirme avoir \u00e9conomis\u00e9 30 millions de dollars en annulant 30 contrats de location avec la FDA\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">7 mars 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/news\/\">Actualit\u00e9s r\u00e9glementaires<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/doge-fda-lease-cancellations\/\" class=\"plain\">Le DOGE revendique des \u00e9conomies de $30M gr\u00e2ce \u00e0 l&#039;annulation de 30 baux de la FDA<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/doge-fda-lease-cancellations\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">\u00c9tats-Unis<\/a> <a href=\"https:\/\/regask.com\/fr\/category\/news\/\" class=\"category-news\">Actualit\u00e9s r\u00e9glementaires<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/france-ansm-ce-mark-exemption\/\" class=\"plain\" aria-label=\"L&#039;ANSM (France) clarifie le processus d&#039;exemption du marquage CE pour\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"L&#039;Ansm France clarifie son processus d&#039;exemption du marquage Ce pour les dispositifs m\u00e9dicaux\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">26 f\u00e9vrier 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/news\/\">Actualit\u00e9s r\u00e9glementaires<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/france-ansm-ce-mark-exemption\/\" class=\"plain\">L&#039;ANSM (France) clarifie le processus d&#039;exemption du marquage CE pour\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLe 27 janvier 2025, l&#039;Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) en France a publi\u00e9 une mise \u00e0 jour cl\u00e9 concernant le processus\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/france-ansm-ce-mark-exemption\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/region\/europe\/france-regulations\/\" class=\"category-france-regulations\">France<\/a> <a href=\"https:\/\/regask.com\/fr\/category\/news\/medical-devices-insights\/\" class=\"category-medical-devices-insights\">Dispositifs m\u00e9dicaux<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-ai-drug-regulation-guidance\/\" class=\"plain\" aria-label=\"La FDA am\u00e9ricaine annonce un projet de lignes directrices sur l\u2019utilisation de l\u2019IA dans les processus r\u00e9glementaires\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA am\u00e9ricaine annonce un projet de guide sur l&#039;utilisation de l&#039;IA dans la prise de d\u00e9cision r\u00e9glementaire sur les m\u00e9dicaments et les produits biologiques\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">22 janvier 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/news\/\">Actualit\u00e9s r\u00e9glementaires<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-ai-drug-regulation-guidance\/\" class=\"plain\">La FDA am\u00e9ricaine annonce un projet de lignes directrices sur l\u2019utilisation de l\u2019IA dans les processus r\u00e9glementaires<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLe 6 janvier 2025, la Food and Drug Administration (FDA) des \u00c9tats-Unis a annonc\u00e9 la publication d&#039;un projet de lignes directrices intitul\u00e9 \u00ab Consid\u00e9rations pour l&#039;U\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-ai-drug-regulation-guidance\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">\u00c9tats-Unis<\/a> <a href=\"https:\/\/regask.com\/fr\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Pharmaceutique et biotechnologie<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-pediatric-drug-meeting\/\" class=\"plain\" aria-label=\"La FDA am\u00e9ricaine annonce une r\u00e9union publique sur la l\u00e9gislation p\u00e9diatrique\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA am\u00e9ricaine annonce une r\u00e9union publique sur l&#039;impact de la l\u00e9gislation p\u00e9diatrique sur le d\u00e9veloppement des m\u00e9dicaments biologiques pour les enfants\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">8 janvier 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/news\/\">Actualit\u00e9s r\u00e9glementaires<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-pediatric-drug-meeting\/\" class=\"plain\">La FDA am\u00e9ricaine annonce une r\u00e9union publique sur la l\u00e9gislation p\u00e9diatrique\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLa Food and Drug Administration (FDA) a programm\u00e9 une r\u00e9union publique intitul\u00e9e \u00ab R\u00e9union des parties int\u00e9ress\u00e9es : mise en \u0153uvre des meilleures pratiques pharmaceutiques\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-pediatric-drug-meeting\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">\u00c9tats-Unis<\/a> <a href=\"https:\/\/regask.com\/fr\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Pharmaceutique et biotechnologie<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-real-world-evidence-center\/\" class=\"plain\" aria-label=\"La FDA (\u00c9tats-Unis) cr\u00e9e un nouveau centre pour les preuves du monde r\u00e9el\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA am\u00e9ricaine cr\u00e9e un nouveau centre d&#039;innovation fond\u00e9 sur des preuves du monde r\u00e9el pour am\u00e9liorer la s\u00e9curit\u00e9 et la surveillance de l&#039;efficacit\u00e9 des m\u00e9dicaments\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">20 d\u00e9cembre 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/news\/\">Actualit\u00e9s r\u00e9glementaires<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-real-world-evidence-center\/\" class=\"plain\">La FDA (\u00c9tats-Unis) cr\u00e9e un nouveau centre pour les preuves du monde r\u00e9el\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLe 12 d\u00e9cembre 2024, la Food and Drug Administration (FDA) des \u00c9tats-Unis a annonc\u00e9 la cr\u00e9ation du Center for Real-World Evidence and Innovation\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/us-fda-real-world-evidence-center\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">\u00c9tats-Unis<\/a> <a href=\"https:\/\/regask.com\/fr\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Pharmaceutique et biotechnologie<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/portuguese-industry-us-alcohol-labels\/\" class=\"plain\" aria-label=\"L&#039;industrie portugaise s&#039;oppose \u00e0 la proposition am\u00e9ricaine de lutte contre le cancer\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"L&#039;industrie portugaise s&#039;oppose \u00e0 notre proposition d&#039;\u00e9tiquetage des boissons alcoolis\u00e9es contre le cancer\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">28 janvier 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/fr\/category\/news\/\">Actualit\u00e9s r\u00e9glementaires<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/portuguese-industry-us-alcohol-labels\/\" class=\"plain\">L&#039;industrie portugaise s&#039;oppose \u00e0 la proposition am\u00e9ricaine de lutte contre le cancer<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tL&#039;autorit\u00e9 sanitaire am\u00e9ricaine envisage d&#039;introduire des \u00e9tiquettes d&#039;avertissement obligatoires contre le cancer sur les boissons alcoolis\u00e9es, une mesure similaire \u00e0 celle\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/fr\/portuguese-industry-us-alcohol-labels\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tEn savoir plus\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/fr\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Pharmaceutique et biotechnologie<\/a> <a href=\"https:\/\/regask.com\/fr\/category\/region\/europe\/portugal-regulations\/\" class=\"category-portugal-regulations\">Portugal<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><\/div>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1680070817 > .col-inner {\n  margin: 0px 0px 80px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_2032346846 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n}\n<\/style>\n\t<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":32,"featured_media":8585,"parent":4916,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-blank.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-8584","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RegASK to sponsor Pharma Japan 2025<\/title>\n<meta name=\"description\" content=\"Join RegASK at Pharma Japan 2025 in The Westin, Tokyo as we showcase our AI-driven regulatory intelligence helping pharmaceutical companies navigate compliance, innovation, and patient-centric transformation in Japan\u2019s evolving pharma landscape.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/evenements\/industrie-pharmaceutique-japonaise-2025\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Japan 2025\" \/>\n<meta property=\"og:description\" content=\"Join RegASK at Pharma Japan 2025 in The Westin, Tokyo as we showcase our AI-driven regulatory intelligence helping pharmaceutical companies navigate compliance, innovation, and patient-centric transformation in Japan\u2019s evolving pharma landscape.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/evenements\/industrie-pharmaceutique-japonaise-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-11T10:15:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png\" \/>\n\t<meta property=\"og:image:width\" content=\"720\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/events\\\/pharma-japan-2025\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/events\\\/pharma-japan-2025\\\/\",\"name\":\"RegASK to sponsor Pharma Japan 2025\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/events\\\/pharma-japan-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/events\\\/pharma-japan-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/RegASK-Pharma-Japan-2025_Landing-Page.png\",\"datePublished\":\"2025-08-19T06:56:00+00:00\",\"dateModified\":\"2026-09-11T10:15:54+00:00\",\"description\":\"Join RegASK at Pharma Japan 2025 in The Westin, Tokyo as we showcase our AI-driven regulatory intelligence helping pharmaceutical companies navigate compliance, innovation, and patient-centric transformation in Japan\u2019s evolving pharma landscape.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/regask.com\\\/events\\\/pharma-japan-2025\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/events\\\/pharma-japan-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/events\\\/pharma-japan-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/RegASK-Pharma-Japan-2025_Landing-Page.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/RegASK-Pharma-Japan-2025_Landing-Page.png\",\"width\":720,\"height\":720,\"caption\":\"Regask Pharma Japan 2025 Landing Page\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/regask.com\\\/events\\\/pharma-japan-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Events\",\"item\":\"https:\\\/\\\/regask.com\\\/events\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma Japan 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RegASK sponsorisera Pharma Japan 2025","description":"Rejoignez RegASK \u00e0 Pharma Japan 2025 au Westin, Tokyo, alors que nous pr\u00e9sentons notre intelligence r\u00e9glementaire bas\u00e9e sur l&#039;IA aidant les soci\u00e9t\u00e9s pharmaceutiques \u00e0 naviguer dans la conformit\u00e9, l&#039;innovation et la transformation centr\u00e9e sur le patient dans le paysage pharmaceutique en \u00e9volution du Japon.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/evenements\/industrie-pharmaceutique-japonaise-2025\/","og_locale":"fr_FR","og_type":"article","og_title":"Pharma Japan 2025","og_description":"Join RegASK at Pharma Japan 2025 in The Westin, Tokyo as we showcase our AI-driven regulatory intelligence helping pharmaceutical companies navigate compliance, innovation, and patient-centric transformation in Japan\u2019s evolving pharma landscape.","og_url":"https:\/\/regask.com\/fr\/evenements\/industrie-pharmaceutique-japonaise-2025\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_modified_time":"2026-09-11T10:15:54+00:00","og_image":[{"width":720,"height":720,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ASKRegASK","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/regask.com\/events\/pharma-japan-2025\/","url":"https:\/\/regask.com\/events\/pharma-japan-2025\/","name":"RegASK sponsorisera Pharma Japan 2025","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/events\/pharma-japan-2025\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/events\/pharma-japan-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png","datePublished":"2025-08-19T06:56:00+00:00","dateModified":"2026-09-11T10:15:54+00:00","description":"Rejoignez RegASK \u00e0 Pharma Japan 2025 au Westin, Tokyo, alors que nous pr\u00e9sentons notre intelligence r\u00e9glementaire bas\u00e9e sur l&#039;IA aidant les soci\u00e9t\u00e9s pharmaceutiques \u00e0 naviguer dans la conformit\u00e9, l&#039;innovation et la transformation centr\u00e9e sur le patient dans le paysage pharmaceutique en \u00e9volution du Japon.","breadcrumb":{"@id":"https:\/\/regask.com\/events\/pharma-japan-2025\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/events\/pharma-japan-2025\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/events\/pharma-japan-2025\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png","width":720,"height":720,"caption":"Regask Pharma Japan 2025 Landing Page"},{"@type":"BreadcrumbList","@id":"https:\/\/regask.com\/events\/pharma-japan-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Events","item":"https:\/\/regask.com\/events\/"},{"@type":"ListItem","position":2,"name":"Pharma Japan 2025"}]},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plateforme d&#039;intelligence artificielle multi-agents pour la veille r\u00e9glementaire et l&#039;orchestration des flux de travail dans le secteur des sciences de la vie et des produits de consommation. RegASK combine des LLM verticaux, une architecture d&#039;IA multi-agents et une communaut\u00e9 mondiale de plus de 1\u00a0800 experts pour fournir une veille r\u00e9glementaire, une analyse d&#039;impact, l&#039;automatisation des processus de conformit\u00e9 et des r\u00e9sultats pr\u00eats pour l&#039;audit dans plus de 160 pays.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/pages\/8584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=8584"}],"version-history":[{"count":1,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/pages\/8584\/revisions"}],"predecessor-version":[{"id":11264,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/pages\/8584\/revisions\/11264"}],"up":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/pages\/4916"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/8585"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=8584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}